http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140137550-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_951ade9cb9f29eb8a29ddae1e2fc87e3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-07 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
| filingDate | 2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dc98313c1d966e30b7fc240f547bc72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c9fff7f60d0ef25480198aa4b87cdc |
| publicationDate | 2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20140137550-A |
| titleOfInvention | Pharmaceutical composition for inhibiting drug-metabolizing enzyme containing thelephoric acid |
| abstract | The present invention relates to a pharmaceutical composition for inhibiting drug metabolizing enzymes containing terephorinic acid as an active ingredient. Terephorinic acid of the present invention strongly inhibits the activity of nine CYP subtypes in vivo, strongly inhibits the activity of eight CYP subtypes by competitive inhibition, and inhibits the activity of proadiphene And thus it can be usefully used as a new pharmaceutical composition for inhibiting nonspecific drug metabolizing enzymes. |
| priorityDate | 2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 363.